DS
KURA icon

DRW Securities’s Kura Oncology KURA Stock Holding History

DRW Securities’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Sell
21,398
-110,776
-84% -$1.05M 0.01% 725
2026
Q1 		$1.07M Buy
132,174
+112,149
+560% +$963K 0.01% 313
2025
Q4 		$208K Buy
+20,025
New +$210K 0.01% 957

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

DRW Securities's KURA Position: Q2 2026 in Review

DRW Securities reduced its Kura Oncology (KURA) stake by 84% in Q2 2026, selling an estimated $1.05M and leaving 21,398 shares worth $235K. The position accounts for 0.01% of the portfolio, ranked #725.

DRW Securities first reported a position in KURA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.07M in Q1 2026. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • DRW Securities held 21,398 shares of Kura Oncology worth $235K as of Q2 2026.
  • DRW Securities sold 110,776 Kura Oncology shares in Q2 2026, an estimated $1.05M.
  • Kura Oncology made up 0.01% of DRW Securities's portfolio in Q2 2026, its #725 holding.
  • DRW Securities first reported a position in Kura Oncology in Q4 2025 and has held it in 3 quarters since.
  • DRW Securities's Kura Oncology position peaked at $1.07M in Q1 2026.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.